AlphaYouMS
Insider selling
Mark Schoenberg sold $2.9M of UroGen Pharma Ltd. (URGN) stock
Mark Schoenberg, Chief Medical Officer of UroGen Pharma Ltd. (URGN), sold 60,677 shares of URGN stock worth $2.9M, per an SEC Form 4 filed Aug 24, 2026.
It was an open-market sale.
The trade happened on Aug 20, 2026, 4 days before it was made public.
URGN has moved -7.7% since the trade date, from $46.80 to $43.20 (Sep 21, 2026 close).
- Traded
- Aug 20, 2026
- Disclosed
- Aug 24, 2026
- Filing delay
- 4 days
- Price since
- -7.7%
- Role
- Chief Medical Officer
- Source
- SEC Form 4
More URGN insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.